Kineticos Disruptor — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Inceptor Bioinceptor.bioinJan 2025SEC filingmedium confidence
Inceptor Bio is a clinical-stage biotechnology company developing cell therapies for cancer, focused on solid tumors.
BiotechHealthtechMorrisville, US
Jason Lawrence(Executive Officer)inMatthias Schroff(Executive Officer, Director)inAbraham S. Maingi(Executive Officer)Shailesh Maingi(Director)inDavid Michael Johnston(Director)
BoardMark Bamforth(Director)in
Board seatShailesh Maingi· per SEC Form D · $3.4M raise · filed Jan 2025
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.